News

Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference

WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…

2 years ago

USGI Medical Receives FDA Approval to Conduct Pivotal Study of the POSE2.0® Incisionless Weight Loss Procedure for Primary Obesity

– Approval of IDE advances Company’s progress to make endoscopic gastroplasty an essential element of the primary obesity treatment algorithm…

2 years ago

Safe Supply Streaming Co. Announces Attendance at Prestigious Microcap Event in Atlantic City

Toronto, Ontario--(Newsfile Corp. - January 31, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply"…

2 years ago

AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope

STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

2 years ago

Larodan Partners With Bioz to Provide Researchers With Scientific Product Validation

PALO ALTO, CA / ACCESSWIRE / January 31, 2024 / Bioz, Inc., a leading AI software company based in Silicon…

2 years ago

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand

MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody useKuros…

2 years ago

IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast

GOTHENBURG, SWEDEN / ACCESSWIRE / January 31, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for…

2 years ago

Defence Therapeutics Completes 1st Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the…

2 years ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,…

2 years ago

Rectangle Health Launches All-in-One Platform to Drive Healthcare Providers’ Growth

VALHALLA, N.Y.--(BUSINESS WIRE)--Rectangle Health, the leader in patient engagement, payments, and office compliance solutions for healthcare providers, today announced the…

2 years ago